Hepatitis C Virus Testing Market Research Report, Share, and Forecast to 2025

Posted by rekha on October 17th, 2019

Precision Business Insights (PBI) in its report titled “Hepatitis C Virus Testing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The Hepatitis C virus testing market size was accounted for US$ XX Mn in 2018 and anticipated to account for US$ 1,276.1 Mn by 2025. Key driver of the global Hepatitis C virus testing market is increasing prevalence of Hepatitis C disease in various countries around the world. For instance, according to World Health Organization 2019, approximately 71 Mn people are living with chronic Hepatitis C virus infection and approximately 400,000 people died from Hepatitis C in 2016. In addition, government initiative regarding awareness of Hepatitis C diagnosis, rise in R&D for the development of innovative diagnostic tests, surge in blood donations, and increase bin healthcare expenditure are anticipated to boost the growth of global Hepatitis C virus testing market. However, lack of awareness about the Hepatitis C in underdeveloped countries and poor reimbursement policies may hamper the growth of global Hepatitis C virus testing market.

Hepatitis C virus testing market segmented on the basis of test type, product type, technique, end user, and region.

For request sample : https://www.precisionbusinessinsights.com/request-sample?product_id=15975

Hepatitis C Antibody Test Segment Expected to Dominate the Market

Based on test type, Hepatitis C virus testing market is segmented into Hepatitis C Antibody Test, Hepatitis C RNA Quantitative Test, Hepatitis C RNA Qualitative Test, Hepatitis C RIBA, Hepatitis C Genotype, and Viral Load. Among all the tests, Hepatitis C antibody test estimated to account for major share in terms of revenue in the global Hepatitis C virus testing market due to high sensitivity and specificity with the test. Moreover, Hepatitis C genotype test growing at prominent growth rate over the forecast years owing to frequent approval for the innovative tests. For instance, in May 2017, Siemens Healthineers received FDA approval for Versant HCV genotype 2.0 assay, second generation line probe assay analyzes the all six HCV genotypes and differentiate between subtypes 1a and 1b.

North America Accounts for Major Revenue Share Hepatitis E Diagnostic Test Market

Precision Business Insights (PBI) hepatitis E diagnostic test market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America accounted for largest share in global Hepatitis C virus testing market and is expected to dominate market over the forecast years due to increasing incidence of Hepatitis C in the region. For instance, according to Center for Disease Control and Prevention 2017, approximately 3,186 cases newly detected with HCV infection. Moreover, favorable reimbursement policies for infectious diseases, rise in health awareness among the population, and increase in healthcare expenditure are boost the market over the forecast years. Europe Hepatitis C virus infection market growing at prominent growth rate over the forecast years owing to adoption of advanced diagnostic tests in the region.

Approval for Newer diagnostic Tests Play Vital Role in Hepatitis E Diagnostics Market

Key players implement various strategies to establish their footprint in the global market, thereby enhancing their sale and outreaching the customers. For instance, In October 2015, Hologic, Inc. received EU regulatory approval for Aptima HCV Quant Dx assay on fully automated Panther to confirm the HCV infection and quantify the viral load.

Key player’s profiles in the report are Abbott Laboratories, Bio Rad Laboratories Inc., Qiagen N.V., Bayer AG, OraSure Technologies, Siemens Healthineers, BioGenex, F. Hoffman-La Roche Ltd., Thermo Fisher Scientific, Inc., and Ortho Clinical Diagnostic Inc.

Detailed Segmentation

By Test Type

o   Hepatitis C Antibody Test

o   Hepatitis C RNA Quantitative Test

o   Hepatitis C RNA Qualitative Test

o   Hepatitis C RIBA

o   Hepatitis C Genotype

o   Viral Loa

By Product Type

o   Kits and Reagents

o   Instruments

o   Others

By Technique

o   Polymerase Chain Reaction Tests

o   Immunoassays

o   Others

By End-User Type

o   Hospitals

o   Diagnostic Centers

o   Blood Donation Centers


o   North America

  • U.S.
  • Canada

o   Europe

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

o   Asia-Pacific

  • China
  • Japan
  • India
  • Rest of Asia Pacific

o   Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

o   Middle East and Africa

  • South Africa
  • Gulf Corporation Council Countries (GCC)
  • Rest of MEA

For more information: https://www.precisionbusinessinsights.com/market-reports/global-hepatitis-c-virus-testing-market/

Like it? Share it!


About the Author

Joined: July 26th, 2019
Articles Posted: 219

More by this author